Nikko Asset Management Americas, Inc. - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 223 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.

Quarter-by-quarter ownership
Nikko Asset Management Americas, Inc. ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2023$17,508,918
+13.3%
2,490,600
-2.3%
0.18%
+3.4%
Q1 2023$15,446,885
-6.4%
2,548,991
-1.5%
0.18%
-25.2%
Q4 2022$16,509,003
-34.6%
2,587,618
-4.1%
0.24%
-26.1%
Q3 2022$25,240,000
-15.0%
2,699,413
-3.6%
0.32%
-12.3%
Q2 2022$29,704,000
-24.3%
2,799,642
+17.7%
0.37%
+27.4%
Q1 2022$39,243,000
-52.5%
2,378,336
-52.1%
0.29%
-33.6%
Q4 2021$82,619,000
-43.0%
4,965,096
-22.2%
0.43%
-30.3%
Q3 2021$144,972,000
-27.0%
6,380,803
-17.4%
0.62%
-19.8%
Q2 2021$198,527,000
+17.3%
7,724,788
+44.5%
0.78%
-6.3%
Q1 2021$169,250,000
-17.5%
5,345,861
+20.8%
0.83%
-28.9%
Q4 2020$205,269,000
+76.7%
4,423,910
+25.7%
1.17%
+13.3%
Q3 2020$116,152,000
+54.1%
3,519,745
+27.8%
1.03%
+4.3%
Q2 2020$75,365,000
+12.3%
2,754,568
+22.9%
0.99%
+56.9%
Q1 2020$67,086,000
+82.7%
2,241,044
+68.9%
0.63%
+8.8%
Q4 2019$36,718,000
+48.7%
1,326,509
-2.2%
0.58%
+31.7%
Q3 2019$24,685,000
-20.4%
1,356,302
+7.3%
0.44%
-27.8%
Q2 2019$30,996,000
+603.8%
1,264,096
+173.0%
0.61%
+424.1%
Q1 2019$4,404,000463,0700.12%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Perceptive Advisors 12,201,261$203,150,0004.07%
Paradigm Biocapital Advisors LP 907,428$15,109,0004.00%
Avoro Capital Advisors LLC 9,125,000$151,931,0002.77%
Logos Global Management LP 1,000,000$16,650,0002.16%
Avidity Partners Management LP 6,043,219$100,620,0002.10%
Orbimed Advisors 6,633,006$110,440,0001.79%
Parametrica Management Ltd 134,679$2,240,0001.66%
Boxer Capital, LLC 1,935,133$32,220,0001.66%
Fairmount Funds Management LLC 389,588$6,487,0001.53%
Long Focus Capital Management, LLC 705,000$11,738,0001.51%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders